Drilon, A., Schoenfeld, A. J., Arbour, K. C., Litvak, A., Ni, A., Montecalvo, J., . . . Riely, G. J. (2019). Exceptional responders with invasive mucinous adenocarcinomas: A phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers. Cold Spring Harb Mol Case Stud.
استشهاد بنمط شيكاغوDrilon, Alexander, et al. "Exceptional Responders With Invasive Mucinous Adenocarcinomas: A Phase 2 Trial of Bortezomib in Patients With KRAS G12D-mutant Lung Cancers." Cold Spring Harb Mol Case Stud 2019.
MLA استشهادDrilon, Alexander, et al. "Exceptional Responders With Invasive Mucinous Adenocarcinomas: A Phase 2 Trial of Bortezomib in Patients With KRAS G12D-mutant Lung Cancers." Cold Spring Harb Mol Case Stud 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.